Healthcare Times YouTube Channel for Hospitals

healthcare-times

Healthcare Times YouTube Channel

The only dedicated Healthcare YouTube Channel promoting the best Hospital brands in India

In Association with

Identity Space – Healthcare Media Agency &

Healthcare Radius, leading B2B healthcare magazine

 

About:  Healthcare Times is an upcoming YouTube channel featuring leading Indian hospital brands and clinics offering wide choices of treatments for individuals seeking medical help. Healthcare Times You Tube channel promotes India as a top medical destination for domestic and international patient in particular. The channel broadcasts eminent leaders in healthcare, their future vision and growth plans, How modern technology is transforming medical treatment in India, Latest trends in healthcare and wellness, Presenting breakthrough medical cases successfully executed  by skilled Indian doctors and much more

Partner:  Content brought in collaboration with Healthcare Radius, India’s leading premier B2B healthcare media by ITP Publishing India

Target audience: Healthcare professionals, Patients [domestics & international], Medical Operators, Facilitators, Health bodies, Accreditation Agencies, Embassies, Insurance Companies, Corporates, Education Institute, Medical Colleges

Promotions: Video links of Healthcare Radius Blog, Usage of social media platforms like Facebook,Twitter & Linkedin and other relevant  partner platforms

Video length & Hosting duration: Video length – 15-20 mins , Hosting duration timeline is sole discretion of Healthcare Times

Cost Implication: Nominal min production & editing cost to be borne at actual.

 

For inquires contact:whatsapp-image-2017-02-09-at-1-45-56-pmIdentity Space | M- 98215 11115 | Email: info@identityspace.in

Six Month Clinical Trial Data Shows First Thin Strut Fully Dissolvable Stent in the World, Developed in India, to be Safe

Six Month Clinical Trial Data Shows First Thin Strut Fully Dissolvable Stent in the World, Developed in India, to be Safe

Findings of the six month clinical trial on the first thin strut fully dissolvable stent in the world, developed in India, were unveiled at the prestigious main arena, Late Breaking Clinical Trials/First Report Investigations at the Cardiovascular Therapeutics (TCT) 2016, Washington DC, on Monday, October 31, at 12:30 pm EST. The TCT is the biggest and best regarded meeting of interventional cardiologists in the world. This was a proud moment for India, as the data was presented by the eminent interventional cardiologist Dr Ashok Seth, Chairman Fortis Escorts Heart Institute, who was the principal investigator of the study.

The study titled MeRes-1 is the first-in-man study of the novel thin-strut PLLA-based sirolimus-eluting bioresorbable vascular stent (MeRes100). It considered Six-Month Clinical, Angiographic, Intravascular ultrasound (IVUS), and Optical coherence tomography (OCT) results in patients with Coronary Artery Disease.

sirolimus

Presenting the findings of the study, Dr. Ashok Seth, MBBS, FRCP,  DSc, Chairman of the Fortis Escorts Heart Institute and Chairman of the Cardiology Council, Fortis Group of Hospitals in New Delhi, India, said, “This is a big day for India and the ‘Make in India’ program.  It also reveals to the world that our Indian device industry has the ability to be innovative, creative and support high quality research. The innovative design of the MeRes100 scaffold developed in India addresses some of the limitations of currently available Bio Resorbable Stents (dissolvable stents) and may have higher success and lower complication rates in the long term.  It would also cost much lesser than the currently available dissolvable stents and therefore give more benefit to higher number of patients.  The MeRes-1, first-in-man study demonstrates that this new generation thinner strut sirolimus eluting BRS is both safe and effective at six months. These encouraging results provide the basis for further studies using wider range of length and sizes in more complex and larger patient population.”

The MeRes100 is a low profile 100µm thin strut PLLA based BRS with a unique hybrid design featuring open cells at the center and closed cells at the edges resulting in improved track-ability and access to side branches. It also has enhanced visibility with three circumferential radio opaque markers at each end.

In this prospective, multicenter, single arm trial of MeRes100 BRS, a total of 108 patients (116 lesions) were enrolled at 16 Indian sites from May 2015 to April 2016. The primary end-point was Major Adverse Cardiac Events (MACE), a composite of cardiac death, myocardial infarction, Ischaemia Driven Target Lesion Revascularization (ID-TLR), and Ischaemia Driven Target Vessel Revascularization (ID-TVR) at six months. The secondary end-point was scaffold thrombosis at six months.  The study found no MACE or stent thrombosis (ST) after the deployment of the scaffold up to six month follow-up. Quantitative Coronary Analysis (QCA) data at six months demonstrated very favorable in scaffold late lumen loss of 0.15±0.26mm. Intravascular ultrasound (IVUS) and Optical coherence tomography (OCT) analysis showed no scaffold recoil and near complete strut coverage (99.3%) with neointima.

The TCT is the annual scientific symposium of the Cardiovascular Research Foundation (CRF) featuring a number of first report investigations on novel stents that could become the next generation of bioresorbable stents in patients.

“Bioresorbable stents (dissolvable stents) have the potential to be greatly impactful in the treatment of coronary artery disease, and it is exciting to see these first report investigations of several new and novel stents advancing the technology forward,” said Ajay Kirtane, MD, SM, and a Co-Director of TCT. He is also Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian Hospital/Columbia University Medical Center and an Associate Professor of Medicine at Columbia University College of Physicians and Surgeons. “These results give us the first insights into their safety and efficacy, but larger randomized trials are necessary in order to establish their role in clinical practice.”

Roche Diagnostics raises the bar on blood screening in the Middle East

Roche Diagnostics raises the bar on blood screening in the Middle East

Today at the 34th International Conference of ISBT in Dubai, United Arab Emirates, Roche Diagnostics introduced powerful blood safety innovations.  These cutting-edge solutions will further enable blood banks in the Middle East and around the world with high-sensitivity blood screening solutions needed to secure blood supplies.  With the aid of these tools, the risk of contaminated blood is significantly reduced. Moreover, patients in need will be provided with safe transfusions as a result of the reduction in manual steps.  The comprehensive portfolio of advanced serology screening and Nucleic Acid Testing (NAT) technologies, delivers industry-leading reliability and workflow efficiency for blood centres, bringing peace of mind to both physicians and patients. 

 Every year, over 108 million blood donations are made worldwide. This transfusion of blood and blood products help save millions of lives yet infectious diseases pose a significant threat on public health; thus, making reliability an unshakable necessity. Reaffirming Roche’s commitment to the highest levels of quality in the Middle East, the Blood Safety Solution by Roche not only brings this reliability to blood banks but also full traceability, excellent cross-contamination controls and less downtime.  The efficiency of laboratories is extended to the fullest when such benefits are advanced from state-of-the-art technologies like Electrochemiluminescence (ELC) and Polymerase Chain Reaction (PCR); resulting in high specificity and NAT real-time-target-discrimination.

 Commenting on this year’s active participation at the International Society for Blood Transfusion, Harald Wolf, General Manager – Roche Diagnostics Middle East, said: “ISBT is a great launchpad to present our Blood Safety Solutions as securing safe blood supplies has become an increasingly important element in healthcare.  We are proud to bring our innovations to the UAE and the Middle East as it delivers reliability and workflow efficiency to blood centres; bringing peace of mind to both patients and physicians in the region. ”

 Renowned worldwide for being first movers and adopters in many fields, the United Arab Emirates has always been at the forefront of securing safe blood supplies by taking significant strides in equipping its blood donation centres across the country with the latest diagnostic technologies available.  Thus, ISBT which is taking place in the UAE for the first time sets the perfect stage to display these innovations locally, regionally and to the world alike.

Advantage India

India’s medical tourism market is expected to grow exponentially, becoming an attractive destination for medical tourists by offering cost-effective quality healthcare

By Dalip Kumar ChopraMTH-2

As healthcare is becoming costlier in developed countries around the globe, India plays an important role in providing quality healthcare at a low cost. India’s medical tourism market is expected to grow from present $3 billion to around $8 billion by 2020. According to the CII – Grant Thornton white paper, cost is a major driver for nearly 80% of medical tourists across the globe.

The cost factor and accredited facilities in Singapore, Thailand, India, Malaysia, Taiwan, Mexico and Costa Rica makes them a destination of choice for the medical tourists. Bangladesh and Afghanistan dominate the Indian Medical Value Travel (MVT) with 34% share. Africa, GCC & CIS Regions (whose current share is just 30%) present the maximum possible opportunity for the Indian healthcare sector. Medical tourists from these sectors currently favour the South East Asian medical corridors. Chennai, Mumbai, Andhra Pradesh and NCR are the most favoured medical tourism destinations for the medical tourists in India. India, one of world’s fastest growing markets for medical tourism, is becoming more popular among Russians seeking better and cheaper options for treatment which is either not available in Russia or requires a long wait. Asian countries are seriously challenging Europe, US and Israel as attractive destinations for medical tourists: people who travel across international borders to obtain healthcare. India, Thailand and Singapore are three countries in Asia that receive the maximum number of medical tourists, because of the quality of healthcare infrastructure and the availability of highly skilled doctors, as well as lower cost of treatment.

Growth Potential
India hosts thousands of medical tourists from the US, Canada, Australia and the UK, as well as from African Countries and Asian neighbours like Bangladesh, Sri Lanka and China yearly. According to ASSOCHAM, in 2011 India saw 850,000 medical tourists and by the end of 2015 this number may rise to 3.2 million. The Indian medical tourism market is expected to expand at a CAGR of 27% to reach $3.9 billion in 2014, from $1.9 billion in 2011, according to the “Medical Value Travel” in India report by KPMG and FICCI. Globally, the medical value travel industry is estimated at $10.5 billion and is expected to grow to $32.5 billion over the next five years at CAGR of 17.9%.

Comparison with Russia
Despite Russia being known in India particularly for the quality of its medical education – consider that eight out of ten Indian students in Russia are enrolled in medicine or dentistry courses – there are multiple factors that make Russian patients seek better healthcare options abroad and more recently, in India too.

The Indian healthcare sector amounted for $78.6 billion in 2012 and is expected to reach approximately $158.2 billion by 2017, according to KPMG. The Russian healthcare sector in the same period, according to PWC, stood at $86 billion. The difference between the two countries is that while in India the healthcare industry has, since 1990s, emerged as a huge segment with dynamic private sector involvement, in Russia it has been dominated by only the government for about 100 years. Today more than 60% of the Russian healthcare market belongs to the government sector, although the share of private healthcare is growing rapidly.

Russian industry analysts stress that, despite Russian doctors being highly qualified, they are not enough, thus leaving smaller regional medical centres poorly staffed and equipped. Misdiagnosis and delayed diagnosis and medical errors are common in the Russian healthcare system as bureaucratic hurdles abound and long queues of people wait for prescribed treatment and quotas for free treatment. Patients, especially children and elderly people, are often considered non–responsive to treatment and are thus denied medical services. Outside Russia, they get medical help in most cases.
India has all the possible ingredients to be an attractive medical tourism destination viz.

  • World renowned Indian doctors ( specialists and super specialists ).
  • Highly skilled nurses and paramedics.
  • World class hospitals with state–of–the-art infrastructure and medical equipment.
  • No language barrier. English being the preferred language used in all hospitals of India. Besides that, there is availability of language interpreters in all Indian hospitals.
  • Excellent Indian hospitality.
  • Low medical treatment cost.
  • Low pre and post treatment and stay cost.

dalip

Dilip Kumar Chopra is the Director with Gurdasmal Hospitality& Consultancy Services Pvt Ltd, Noida

The Birthplace – Superior Clinical Care

birthplace

The Birthplace is the ultimate destination for every mother-to-beMTHlogo

The Birthplace is a unique facility at Hyderabad that addresses the entire spectrum of women’s health issues spanning from PCOS, endometriosis, infertility and other conditions, to pregnancy, reconstructive surgeries and more. Being a 25-bed boutique facility, it allows the hospital to focus all its time and attention into providing the very best care, making it all as warm and personal as possible.

Apart from providing superior clinical care for almost every health concern that women face, the Birthplace is also the ultimate destination for every mother-to-be. The teams provide personalised family-centred care, which means partnering with patients to tailor to their experience, specific to their needs. Their approach is reflected across our services including fertility and preconception, prenatal diagnostics, foetal and pregnancy health, obstetric care, labour and delivery, maternity, neonatology, comfort techniques for labour and developmental paediatrics.

At Birthplace, there’s always someone to make sure that everything is executed to perfection. A stunning lobby, exquisite rooms, high-end entertainment systems, Wi-Fi connectivity, a super-comfortable
to pamper patients, luxurious shower cabinets and germ resistant carpeting add a dash of luxury and comfort.

The patients gain access to world-class clinical expertise with a designated executive to cater to their every whim. The hospital conducts regular sessions like yoga and lamaze, and offer a range of delivery options, including water births. The doctors also advise patients on how they can still consider a normal birth, even if they have had a C-section in the past. All this at a package price that holds no unpleasant surprises at check-out.

At service is the most advanced 4D ultrasound machine in the world, high-tech operation suites and an industry-best NICU facility, complemented by a world-class team of obstetricians, nurses and counsellors.

The hospital offers the following specialties:

  • Fertility and Gynaecology.
  • High Risk Obstetrics and Neonatology.
  • Cosmetic and Reconstructive Surgeries.
  • Weight Loss Surgeries / Metabolic Surgeries.
  • Urology, General and Minimal Access Surgeries.

For International Patients
The Birthplace is a hospital that can cater to the needs of patients from across the world within its top-notch boutique facility. The company extends a warm welcome to international guests, along with an assurance that they can expect a lot more than great healthcare solutions here.

  • Birthplace offers a range of treatments and will help patients with all the information they need before they decide to make the trip to India.
  • Patients are assigned a single point of contact, once they connect with the Birthplace, who will assist them in everything from scheduling doctors’ appointments to currency conversions.
  • The staff is attentive and sensitive to the patient’s every need. Right from picking them up from the airport and checking them into a luxurious hotel the Birthplace, to hassle-free consultation and discharge.
  • The Birthplace help patients with formalities like getting their permits / VISA processed, and plan their entire stay beforehand.
  • The clinical infrastructure consists of some of the best equipment in the world, including world-class operation theatres, monitoring systems, a 4D ultrasound and an advanced NICU.
  • The doctors, technicians, nurses and other staff are qualified, well-trained and among the best in the industry, not to mention extremely warm and approachable.

Be a Guest Blogger

bloggerWelcome Guest BloggerThank you for responding to our mailer,now you can be a guest blogger at Healthcare Radius Blog. This is an open invitation to pen articles and your thoughts on healthcare system in our country, it can be new trends, health policies, management, medical technologies or just your views on recent happenings in Healthcare industry. This is a b2b blog hence all readers are  from core healthcare sector, please note that all post will be moderated by our editor and will be published after scrutinizing the content. Request you to provide the details in the form below.We will soon get back to with as we get your request. Thank you

[contact-form][contact-field label=’Name’ type=’name’ required=’1’/][contact-field label=’Hospital / Organisation Name’ type=’text’ required=’1’/][contact-field label=’Designation’ type=’text’ required=’1’/][contact-field label=’Mobile No’ type=’text’ required=’1’/][contact-field label=’Email’ type=’email’ required=’1’/][contact-field label=’I wish to blog on topic like’ type=’text’ required=’1’/][/contact-form]

Healthcare IT – Invitation for contributory articles

Health-IT_NewsDear Contributor,

Healthcare Radius is India’s premier healthcare magazine, recently we have been getting good reviews and feedback from our readers on Health IT articles currently published. We would like to collaborate with expert health IT professionals in delivering more valuable health IT content to readers. Thank you for coming to this page, if you are keen to contribute Health IT articles please provide details below. We will reach  you soon.

Looking forward to your interesting contributions for Healthcare Radius.

[contact-form][contact-field label=’Person Name’ type=’text’ required=’1’/][contact-field label=’Company Name’ type=’text’ required=’1’/][contact-field label=’Designation’ type=’text’/][contact-field label=’Mobile No’ type=’text’ required=’1’/][contact-field label=’Email’ type=’email’ required=’1’/][contact-field label=’City’ type=’text’ required=’1’/][contact-field label=’Website’ type=’url’ required=’1’/][contact-field label=’I like to contribute articles on:’ type=’textarea’ required=’1’/][/contact-form]

 

Dr V Mohan, Chairman & Chief of Diabetology – Focus on Research

Dr V Mohan, Chairman & Chief of Diabetology, Dr Mohan’s Diabetes Specialities Centre, talks about the unique services offered by his groupMTHlogo

drvmohan

Within a span of 25 years, Dr Mohan’s DSC has blossomed into an international centre of excellence. What has been the key to your institute’s success?
I have been working in the field of diabetes, since my undergraduate days. I was lucky to be mentored by my fath
er, late Professor M Viswanathan, considered as the ‘Father of Diabetology’ in India. This early start and the first 20 years that I spent with my father at his institute, the MV Hospital for Diabetes, helped us to develop Dr Mohan’s Diabetes Specialities Centre into a world class institute. We established this centre in 1991 and subsequently the centre has grown to have its presence in many parts of India and even abroad.

Please tell us about the USP of Dr Mohan’s DSC. What are the unique services that you offer?
We offer ‘total diabetes care’ i.e. offer all diabetes specialities under one roof. This is a concept which we evolved in the early 1980s and have perfected over the years. Moreover, we have a very strong research base through our sister institution, ‘The Madras Diabetes Research Foundation’. We are always innovating in the space of diabetes therapy, prevention and in etiology of diabetes. This always keeps us ahead and helps us to innovate because we believe that ‘Today’s research is tomorrow’s treatment’.

Share with us about the initiatives taken by your speciality centre to build Dr Mohan’s DSC brand identity in the healthcare industry.
From the beginning, we have insisted that we will maintain ‘world class quality’. We were the first to introduce Electronic Medical Records. Today , we have 3,70,000 patients in our diabetes electronic records which by far is the largest in the world. We were also the first to introduce several new innovations in the country. For instance, we were the first to set up a separate eye unit for diabetic retinopathy and many other innovations. Recently, we have set up our genetics division and through this, we are able to accurately genotype our patients which helps in providing personalised treatment to our patients. All these have helped to build Dr Mohan’s brand in the healthcare industry.

Your centre has been doing phenomenal service to the Indian community. How have you poised yourself to treat patients beyond borders? What special services do you offer for international patients?
We have already started a centre in Muscat, Oman which is doing well. We hope to take the same world class services that we offer in India to our international patients as well and expand to other countries.

Do you see any challenges treating international patients? How do you manage the treatment modality?
I don’t see any special challenges in treating international patients. We do get patients from Muscat, Dubai, Saudi Arabia, Qatar, Sri Lanka, Malaysia, Singapore, Nigeria, Tanzania, Kenya, South Africa and even from the UK, the US and Canada who come to us for our specialised treatment. After the initial treatment at our centre at our main headquarters in Gopalapuram, we do offer email consultations for sometime till they come back to our centre for their review.

Can you highlight some diabetes disease profile that is prevalent with international patients. How different is the disease profile compared to our disease profile?
Many of the patients who come from abroad are overweight or frankly obese and hence insulin resistance is an added problem with these patients. Moreover, many of the patients only come when they develop complications like foot complications. A common scenario is that when a doctor advises an amputation, they rush to our centre – hoping we can save the foot. If we create greater awareness, we can get patients to come at earlier stages, thereby offer even better treatment to them.

What steps are required to be taken by healthcare entities to propel the growth of
for our country?

There is a lot of potential for medical tourism because India offers world class care at an affordable rate.
However, a lot of marketing and creation of awareness is needed.

Can you share your future vision for Dr Mohan’s DSC.
Till now, we have been mainly focused on Chennai, Tamil Nadu and Hyderabad. In the near future, we hope to become a pan-India brand and also spread our wings to several countries in the Middle East and Africa.

Jaslok Hospital and Research Centre – Healthcare Par Excellence

Jaslok Hospital and Research Centre sets new milestone in healthcare excellence

dr-tarandMTHlogo

Jaslok Hospital and Research Centre, a name well known for superior healthcare, has set new benchmarks in medical excellence in the last financial year by extending an unparalleled experience of care, compassion and tenderness to its patients. The highly structured approach to clinical excellence has made Jaslok to be ahead of the curve. It strives for technological excellence, leaving no stone unturned when it comes to providing patients world class treatment in all specialities by continuously learning and adopting the best practices to ensure our patients have access to cutting-edge technology.
The state-of-the-art services in Cardiac Care, Neuro Care, Oncology, Orthopaedics and emergency care has made Jaslok one of the most preferred healthcare centres in India by foreign patients. The international health desk at Jaslok Hospital is a full-service office that assists overseas patients seeking a consultation, or medical treatment works towards providing seamless service tailored to personal and cultural expectations of patients from abroad. Senior delegates from Central Bank of Nigeria (CBM), Israel and Singapore consulates have appreciated Jaslok for the supreme quality health care service.
Jaslok Hospital, which holds ‘care with comfort’ strategy in high regards, has a dedicated separate floor for foreign patients to ensure a pleasant and comfortable stay with all facilities including nurse call systems, television, refrigerator and telephone facility during their treatment. The hospital also ensures that special cuisines are served for international patients coming in from various regions.

The year has also witnessed launching of several cutting edge technologies at Jaslok hospital. The Department of Nuclear Medicine at the Jaslok Hospital pioneered to get a triple-head gamma camera and the first solid-state dedicated cardiac camera in Asia has added a five ring 16-slice PET-CT scanner to the list, becoming first in Asia.

The launching of Multidisciplinary Robotic Programme at Jaslok Hospital is yet another landmark in the newer technology and armamentarium at this renowned institution. The department involves multi-specialty approach of urologists, gynaecologists, onco-surgeons, general surgeon, paediatric surgeons, cardiac surgeons and transplant surgeons. Jaslok Hospital has launched a Jain kitchen to cater to the needs of their Jain patients, their relatives attending them and employees.

The Hospital has been recognised for its unparalleled excellence with many awards and recognitions last year including ‘India’s Most Trusted Brand Awards- 2015’. Jaslok has been featured in ‘The Week Magazine, 2015 and is Ranked fifth for Best Multi-specialty Hospital in Mumbai. Times Health Survey has selected Jaslok Hospital as the best in most of the specialities in the city and country also Ranked number two in the entire West zone and Mumbai region and Number six in the national ranking in All India Multi-specialty Hospital Ranking Survey 2016. “Quality beyond accreditation” in AHPI Global Conclave has added another feather to Jaslok’s cap of superior healthcare. Jaslok was successful in achieving reaccreditation by National Accreditation Board for Hospitals & Healthcare Providers (NABH), for setting benchmarks for progress of health care industry in 2015.

Jaslok is proud to have the most supportive board of trustees (Chanrai family), who are the real philanthropists behind the hospital’s progress. I am indeed proud to be a part of the Jaslok family and envision this legendary hospital to go from strength to strength.